Logo image of DNA

GINKGO BIOWORKS HOLDINGS INC (DNA) Stock Analyst Earnings Estimates

NYSE:DNA - New York Stock Exchange, Inc. - US37611X2099 - Common Stock - Currency: USD

10.82  -0.61 (-5.34%)

After market: 10.93 +0.11 (+1.02%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
DNA revenue by date.DNA revenue by date.
313.8M
309.13%
477.7M
52.23%
251.455M
-47.36%
230.02M
-8.52%
205.84M
-10.51%
255.55M
24.15%
611.96M
139.47%
1.137B
85.80%
1.557B
36.94%
2.115B
35.84%
EBITDA
YoY % growth
DNA ebitda by date.DNA ebitda by date.
-1.799B
-1,361.28%
-2.12B
-17.83%
-505.514M
76.16%
-315.006M
37.69%
-139.392M
55.75%
-65.468M
53.03%
-294.516M
-349.86%
1.186B
502.69%
1.951B
64.50%
2.176B
11.53%
EBIT
YoY % growth
DNA ebit by date.DNA ebit by date.
-1.829B
-1,234.67%
-2.163B
-18.28%
-576.021M
73.37%
-532.107M
7.62%
-330.819M
37.83%
-239.174M
27.70%
-558.429M
-133.48%
N/AN/AN/A
Operating Margin
DNA operating margin by date.DNA operating margin by date.
-582.70%-452.75%-229.08%-231.33%-160.72%-93.59%-91.25%N/AN/AN/A
EPS
YoY % growth
DNA eps by date.DNA eps by date.
N/A-49.20
-512.86%
-18.80
61.79%
-10.02
46.71%
-7.44
25.78%
-5.90
20.72%
-0.23
96.06%
-0.10
56.52%
-0.01
90.00%
0.10
1,100.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.79
59.37%
-2.17
32.04%
-2.01
28.22%
-1.91
-102.72%
-1.82
-1.69%
-2.31
-6.35%
-2.12
-5.53%
-1.98
-3.89%
-1.89
-3.89%
Revenue
Q2Q % growth
44.909M
29.22%
47.078M
24.07%
50.049M
-10.95%
53.12M
-40.35%
62.873M
40.00%
51.51M
9.41%
60.6M
21.08%
72.316M
36.14%
78.174M
24.34%
EBITDA
Q2Q % growth
-51.22M
-517.88%
-34.242M
76.53%
-31.664M
74.32%
-29.418M
-417.65%
-20.2M
60.56%
-21.715M
36.58%
-11.615M
63.32%
2.121M
107.21%
1.919M
109.50%
EBIT
Q2Q % growth
-92.043M
-58.01%
-99.313M
37.44%
-91.332M
40.50%
-87.264M
-64.49%
-42.925M
53.36%
-71.71M
27.79%
-55.55M
39.18%
-37.774M
56.71%
-33.936M
20.94%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.94
85.31%
-2.751.8165.88%
Q2 2024
Q2Q % growth
-2.80
22.22%
-3.150.3511.14%
Q1 2024
Q2Q % growth
-3.20
27.27%
-3.370.174.95%
Q4 2023
Q2Q % growth
-4.40
-22.22%
-3.91-0.49-12.66%
Q3 2023
Q2Q % growth
-6.40
60.98%
-3.46-2.94-84.83%
Q2 2023
Q2Q % growth
-3.60
79.07%
-3.41-0.19-5.72%
Q1 2023
Q2Q % growth
-4.40
63.33%
-3.64-0.76-21.01%
Q4 2022
Q2Q % growth
-3.60
90.91%
-8.434.8357.28%
Q3 2022
Q2Q % growth
-16.40
-583.33%
-11.96-4.44-37.14%
Q2 2022
Q2Q % growth
-17.20 -1.75-15.45-882.56%
Q1 2022
Q2Q % growth
-12.00 -1.35-10.65-791.18%
Q4 2021
Q2Q % growth
-39.60 -1.75-37.85-2,162.17%
Q3 2021
Q2Q % growth
-2.40 -1.41-0.99-69.73%
DNA Yearly EPS VS EstimatesDNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30 -40 -50
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
89.046M
60.65%
45.45M43.596M95.92%
Q2 2024
Q2Q % growth
56.206M
-30.24%
43.568M12.638M29.01%
Q1 2024
Q2Q % growth
37.944M
-52.98%
46.504M-8.56M-18.41%
Q4 2023
Q2Q % growth
34.755M
-64.64%
42.927M-8.172M-19.04%
Q3 2023
Q2Q % growth
55.43M
-16.52%
48.557M6.873M14.15%
Q2 2023
Q2Q % growth
80.568M
-44.28%
72.296M8.272M11.44%
Q1 2023
Q2Q % growth
80.702M
-52.08%
72.397M8.305M11.47%
Q4 2022
Q2Q % growth
98.3M
-33.80%
89.547M8.753M9.77%
Q3 2022
Q2Q % growth
66.4M
-14.43%
60.959M5.441M8.93%
Q2 2022
Q2Q % growth
144.6M
231.65%
78.402M66.198M84.43%
Q1 2022
Q2Q % growth
168.4M
281.86%
106.74M61.66M57.77%
Q4 2021
Q2Q % growth
148.5M
362.62%
95.755M52.745M55.08%
Q3 2021
Q2Q % growth
77.6M
483.46%
46.208M31.392M67.94%
DNA Yearly Revenue VS EstimatesDNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -3060.71% 1.88% 21.99%
Revenue0% -15.2% 0% 22.76%